Odonate Therapeutics Pink Sheet Forward View - Simple Regression
| ODTC Stock | USD 50,000 0.00 0.00% |
Odonate Pink Sheet outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Odonate Therapeutics stock prices and determine the direction of Odonate Therapeutics's future trends based on various well-known forecasting models. We suggest always using this module together with an analysis of Odonate Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
At the present time the relative strength index (rsi) of Odonate Therapeutics' share price is below 20 . This indicates that the pink sheet is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Using Odonate Therapeutics hype-based prediction, you can estimate the value of Odonate Therapeutics from the perspective of Odonate Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Regression forecasted value of Odonate Therapeutics on the next trading day is expected to be 50,000 with a mean absolute deviation of 0.00 and the sum of the absolute errors of 0.00. Odonate Therapeutics after-hype prediction price | USD 50000.0 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Odonate |
Odonate Therapeutics Additional Predictive Modules
Most predictive techniques to examine Odonate price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Odonate using various technical indicators. When you analyze Odonate charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Odonate Therapeutics Simple Regression Price Forecast For the 7th of February
Given 90 days horizon, the Simple Regression forecasted value of Odonate Therapeutics on the next trading day is expected to be 50,000 with a mean absolute deviation of 0.00, mean absolute percentage error of 0.00, and the sum of the absolute errors of 0.00.Please note that although there have been many attempts to predict Odonate Pink Sheet prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Odonate Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Odonate Therapeutics Pink Sheet Forecast Pattern
| Backtest Odonate Therapeutics | Odonate Therapeutics Price Prediction | Research Analysis |
Odonate Therapeutics Forecasted Value
In the context of forecasting Odonate Therapeutics' Pink Sheet value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Odonate Therapeutics' downside and upside margins for the forecasting period are 50,000 and 50,000, respectively. We have considered Odonate Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Regression forecasting method's relative quality and the estimations of the prediction error of Odonate Therapeutics pink sheet data series using in forecasting. Note that when a statistical model is used to represent Odonate Therapeutics pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | -9.223372036854776E14 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0 |
| MAPE | Mean absolute percentage error | 0.0 |
| SAE | Sum of the absolute errors | 0.0 |
Predictive Modules for Odonate Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Odonate Therapeutics. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Odonate Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Odonate Therapeutics After-Hype Price Density Analysis
As far as predicting the price of Odonate Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Odonate Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Odonate Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Odonate Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Odonate Therapeutics' pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Odonate Therapeutics' historical news coverage. Odonate Therapeutics' after-hype downside and upside margins for the prediction period are 50,000 and 50,000, respectively. We have considered Odonate Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Odonate Therapeutics is very steady at this time. Analysis and calculation of next after-hype price of Odonate Therapeutics is based on 3 months time horizon.
Odonate Therapeutics Pink Sheet Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Odonate Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Odonate Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Odonate Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 4 Events / Month | 1 Events / Month | In about 4 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
50,000 | 50,000 | 0.00 |
|
Odonate Therapeutics Hype Timeline
Odonate Therapeutics is now traded for 50,000. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Odonate is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is now at 0.0%. %. The volatility of related hype on Odonate Therapeutics is about 0.0%, with the expected price after the next announcement by competition of 50,000. The company has price-to-book ratio of 0.89. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Odonate Therapeutics recorded a loss per share of 2.71. The entity had not issued any dividends in recent years. Given the investment horizon of 90 days the next anticipated press release will be in about 4 days. Check out Historical Fundamental Analysis of Odonate Therapeutics to cross-verify your projections.Odonate Therapeutics Related Hype Analysis
Having access to credible news sources related to Odonate Therapeutics' direct competition is more important than ever and may enhance your ability to predict Odonate Therapeutics' future price movements. Getting to know how Odonate Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Odonate Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| JDHIY | JD Health International | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| ESALY | Eisai Co | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| HURA | TuHURA Biosciences | (0.06) | 10 per month | 0.00 | (0.34) | 7.73 | (10.53) | 50.34 | |
| GNBT | Generex Biotechnology Corp | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| IMVIQ | IMV Inc | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SRNEQ | Sorrento Therapeutics | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| IMUN | Immune Therapeutics | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| GLSHQ | Gelesis Holdings | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| TCON | TRACON Pharmaceuticals | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Forecasting Options for Odonate Therapeutics
For every potential investor in Odonate, whether a beginner or expert, Odonate Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Odonate Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Odonate. Basic forecasting techniques help filter out the noise by identifying Odonate Therapeutics' price trends.Odonate Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Odonate Therapeutics pink sheet to make a market-neutral strategy. Peer analysis of Odonate Therapeutics could also be used in its relative valuation, which is a method of valuing Odonate Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Odonate Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Odonate Therapeutics pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Odonate Therapeutics shares will generate the highest return on investment. By undertsting and applying Odonate Therapeutics pink sheet market strength indicators, traders can identify Odonate Therapeutics entry and exit signals to maximize returns.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 50000.0 | |||
| Day Typical Price | 50000.0 |
Story Coverage note for Odonate Therapeutics
The number of cover stories for Odonate Therapeutics depends on current market conditions and Odonate Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Odonate Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Odonate Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Odonate Therapeutics Short Properties
Odonate Therapeutics' future price predictability will typically decrease when Odonate Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Odonate Therapeutics often depends not only on the future outlook of the potential Odonate Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Odonate Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 32.9 M | |
| Cash And Short Term Investments | 157.3 M |
Other Information on Investing in Odonate Pink Sheet
Odonate Therapeutics financial ratios help investors to determine whether Odonate Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Odonate with respect to the benefits of owning Odonate Therapeutics security.